All hospitals were already participating in the Get With The Guidelines-Stroke program and providing excellent care.
Zacks Investment Research on MSN
CBLL wins FDA breakthrough status for AI-based LVO stroke detection
CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...
Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...
Treatment of acute stroke, before a distinction can be made between ischemic and hemorrhagic types, is challenging. Whether very early blood-pressure control in the ambulance improves outcomes among ...
Patients with ischemic stroke on antiplatelet therapy are at a significantly higher risk for symptomatic intracranial hemorrhage (sICH) following thrombolysis, but the absolute increased risk is small ...
A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...
AJMC®: In your experience, what are the most significant long-term clinical effects of a recurrent stroke? RUSSMAN: Recurrent strokes tend to have more severe long-term clinical effects than initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback